Published in
Elsevier, Seminars in Cancer Biology, (52), p. 16-25, 2018
DOI: 10.1016/j.semcancer.2017.10.003
Links
Tools
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Journal article published in 2018 by
Maria Vittoria Dieci,
Nina Radosevic-Robin,
Susan Fineberg,
Gert van den Eynden,
Nils Ternes,
Frederique Penault-Llorca,
Giancarlo Pruneri,
Timothy M. D’Alfonso,
Sandra Demaria 
,
Carlos Castaneda,
Joselyn Sanchez,
Sunil Badve,
Stefan Michiels ,
Veerle Bossuyt,
Federico Rojo
and other authors.
,
Carlos Castaneda,
Joselyn Sanchez,
Sunil Badve,
Stefan Michiels ,
Veerle Bossuyt,
Federico Rojo
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 